Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - NAFLD_Plasma/Stool/Diet samples

ABSTRACT: Non-alcoholic Fatty liver disease Stool, Diet and Plasma Samples

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter Dorrestein

PROVIDER: MSV000096602 | GNPS | Thu Dec 05 17:23:00 GMT 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

NAFLD_Plasma/Stool/Diet samples

Project description:Non-alcoholic Fatty liver disease Stool, Diet and Plasma Samples

2024-12-05 | MSV000096602 | MassIVE

Transcriptional profiling of hepatic macrophages isolated from mice with high-fat diet -induced non-alcoholic fatty liver disease

Project description:Purpose: The goals of this study were to identify preferential gene expression signatures that are unique to hepatic macrophages in high-fat diet -induced non-alcoholic fatty liver disease. Methods and results: Wild-type and Casp11-/- mice were treated with high fat and normal chow diet for a period of 12 weeks. Hepatic macrophages from liver were isolated to generate mRNA transcription. Conclusion: Our study represents detailed analysis of caspase-11 in regulating hepatic macrophages in high-fat diet -induced non-alcoholic fatty liver disease.

2023-01-17 | GSE221005 | GEO

ChREBPα protects against diet-induced non-alcoholic fatty liver disease

Project description:ChREBPα protects against diet-induced non-alcoholic fatty liver disease

| PRJNA927023 | ENA

Low carbohydrate diet study for non-alcoholic fatty liver disease patients

Project description:Low carbohydrate diet study for non-alcoholic fatty liver disease patients

| PRJNA420975 | ENA

Different expression of non-alcoholic fatty liver disease in rats induced by high-fat diet

Project description:This study aimed to investigate the effect and underlying mechanism of Didymin on lipid metabolic disturbance in rats with non-alcoholic fatty liver disease (NAFLD). Rats were administrated with a high-fat diet (HFD) for 8 weeks to induce NAFLD, followed by different dose Didymin treatment for further 8 weeks.

2023-01-09 | GSE222093 | GEO

microRNA data from high-fat diet fed mice with and without exercise

Project description:Non-alcoholic fatty liver disease (NAFLD) is associated with obesity and lifestyle. Exercise is known to be beneficial for NAFLD treatment. Recent studies have shown the critical involvement of microRNA in NAFLD. However, it is unclear whether exercise could prevent NAFLD via miRNA targeting. We used microarrays to examine microRNA profiles in high-fat diet fed mice with and without exercise in comparison to normal diet fed mice.

2017-02-09 | GSE65978 | GEO

Transcriptomic profile of non-alcoholic fatty liver disease in rat induced by high-fat diet

Project description:This study aimed to investigate the effect and underlying mechanism of Smilax china L. Saponins (SCS) on lipid metabolic disturbance in rats with non-alcoholic fatty liver disease (NAFLD). Rats were administrated with a high-fat diet (HFD) for 8 weeks to induce NAFLD, followed by SCS treatment for further 8 weeks.

2021-12-02 | GSE189855 | GEO

Low dose perfluorooctanesulfonic acid (PFOS) and perfluorohexanesulfonic acid (PFHxS) augment hepatic steatosis and shift the sera lipidome in a high fat high carbohydrate diet.

Project description:Non-alcoholic fatty liver disease (NAFLD) is most prevalent form of liver disease, affecting over 30% of Americans. Perfluoroalkyl substances (PFAS) represent a family of environmental toxicants that have infiltrated the living world. This study explores diet-PFAS interactions and their potential role in the increasing global incidence of NAFLD. Male C57BL/6 mice were fed with either a low-fat diet (11% kcal from fat) or a high fat (58% kcal from fat) high carbohydrate (42g/L) diet with or without PFOS or PFHxS in feed (0.0003% w/w) for 29 weeks. Proteomic, lipidomic, and gene expression measurement techniques were utilized to explore mechanistic pathways. With administration of a high fat high carbohydrate (HFHC) diet, PFOS and PFHxS augmented macrovesicular steatosis, indicative of fatty liver. There was a clear shift in the lipidome of the serum phosphatidylcholines, phosphatidylethanolamines, and triglycerides with PFAS exposure. Finally, chain length exerted significant influence on tissue partitioning and the resulting hepatic gene and protein signatures of PFHxS and PFOS in vivo.

2020-09-15 | PXD015976 | Pride

Expression data from hepatocyte specific Klf6 knockout mice vs. control on high fat diet

Project description:Dysregulated glucose homeostasis and lipid accumulation characterize non-alcoholic fatty liver disease (NAFLD), but underlying mechanisms are obscure. We report here that KrÃ¼ppel-like factor 6 (KLF6), a ubiquitous transcription factor that promotes adipocyte differentiation, also provokes the metabolic abnormalities of NAFLD. Mice with either hepatocyte-specific knockdown of KLF6 (DeltaHepKlf6) or global KLF6 heterozygosity (Klf6 +/-) have reduced body fat content and improved glucose and insulin tolerance. Mice with KLF6 depletion, compared to wild type mice, are protected from high fat diet-induced steatosis. Three mice with a hepatocyte-specific knockdown of KLF6 (DeltaHepKlf6) on high fat diet and 3 littermate controls on the same diet were sacrificed after 8 weeks of diet. Liver tissue was preserved in RNAlaterÂ® (Ambion, Austin, TX). RNA was isolated from liver tissue and homogenized in TRIzolÂ® reagent (Invitrogen, Carlsbad, CA). In order to identify potential KLF6 targets that contributed to changes in glucose- and lipid-metabolism, we performed an Affymetrix Exon1 S.T. GenearrayÂ® (Affymetrix, Santa Clara, CA).

2012-03-23 | E-GEOD-36724 | biostudies-arrayexpress

Transcriptomic analysis of high-fat diet-fed mice treated with CYP4A inhibitors

Project description:Cytochrome P4504A (CYP4A) is known to be related to the development of type 2 diabetes (T2DM) and non-alcoholic fatty liver disease (NAFLD). We discovered selective CYP4A inhibitors, C481 (C1) and C482 (C2), and confirmed the therapeutic effects of these inhibitors on T2DM and NAFLD. In order to confirm the mechanisms of C1 and C2, inhibitors were treated in high-fat diet (HFD)-fed mice and RNA sequencing was performed using the liver tissues.

2024-11-06 | GSE229697 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data